Axogen, Inc. - Common Stock (NQ:AXGN)Price and VolumeDetailed Quote
Top NewsMore News
From Axogen, Inc.
Via GlobeNewswire
Performance
52-Week Range
4.5% below 52-week high
50.55
21.9352W Low
52.9152W High
1 Week
1.2% below 1-week high
37.231W Low
51.161W High
Axogen, Inc. - Common Stock (AXGN) traded between $21.93 and $52.91 over the past 52 weeks and last traded at $50.55, 4.5% below its 52-week high. Over the past week it ranged between $37.23 and $51.16.
Past 12 Months
+34.9%
+35.8%
+10.5%
+18.6%
+63.1%
+117.4%
1W
+$13.09
1M
+$13.33
3M
+$4.82
6M
+$7.92
YTD
+$19.55
1Y
+$27.30
AXGN was +117.4% over the past year, +18.6% over six months, +63.1% year to date, +34.9% in the last week.
12 Months vs Market
AXGN
DIA
SPY
QQQ
IWM
Over the past 12 months AXGN returned +117.4% versus DIA (Dow) +9.4%, SPY (S&P 500) +10.7%, QQQ (Nasdaq 100) +8.8% and IWM (Russell 2000) +14.8%.
Volume & Liquidity
0.14× 3-mo avg
Today 197,585
3-mo avg 1.4M
1W
1M
3M
6M
YTD
1Y
AXGN most recently traded 197,585 shares against a 3-month average daily volume of 1.4M. More NewsRead More
Top US Stock Movers in Today's Session ↗
October 28, 2026
Via Chartmill
Axogen (AXGN) Q3 2026 Earnings Call Transcript ↗
October 28, 2026
Via The Motley Fool
Topics
Earnings
US Top Movers: Biggest Gainers and Decliners in Today's Session ↗
October 28, 2026
Via Chartmill
Oct. 28 Gap Stocks: Double-Digit Gap-Up and Gap-Down Movers ↗
October 28, 2026
Via Chartmill
Premarket Movers for Oct. 28, 2026: Gainers and Losers ↗
October 28, 2026
Via Chartmill
Axogen, Inc. Reports Third Quarter 2026 Financial Results
October 28, 2026
From Axogen, Inc.
Via GlobeNewswire
From Axogen, Inc.
Via GlobeNewswire
Wound Care Stocks Are Posting Double-Digit Growth. Here’s Why.
October 06, 2026
From Wall Street Investor
Via GlobeNewswire
3 Emerging Biotech Stocks With Significant Upside Potential ↗
September 30, 2026
Via MarketBeat
Topics
Intellectual Property
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
September 10, 2026
From Axogen, Inc.
Via GlobeNewswire
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
September 10, 2026
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
September 01, 2026
From Axogen, Inc.
Via GlobeNewswire
Axogen (AXGN) Q2 2026 Earnings Call Transcript ↗
August 07, 2026
Via The Motley Fool
Topics
Earnings
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
August 11, 2026
From Biotech Insider
Via GlobeNewswire
AxoGen Q2 Earnings Call Highlights ↗
July 29, 2026
Via MarketBeat
Topics
Earnings
From Axogen, Inc.
Via GlobeNewswire
From Energy Metal News
Via GlobeNewswire
Frequently Asked QuestionsIs Axogen, Inc. - Common Stock publicly traded?
Yes, Axogen, Inc. - Common Stock is publicly traded.
What exchange does Axogen, Inc. - Common Stock trade on?
Axogen, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Axogen, Inc. - Common Stock?
The ticker symbol for Axogen, Inc. - Common Stock is AXGN on the Nasdaq Stock Market
What is the current price of Axogen, Inc. - Common Stock?
The current price of Axogen, Inc. - Common Stock is 50.55
When was Axogen, Inc. - Common Stock last traded?
The last trade of Axogen, Inc. - Common Stock was at 11/03/26 11:10 AM ET
What is the market capitalization of Axogen, Inc. - Common Stock?
The market capitalization of Axogen, Inc. - Common Stock is 2.09B
How many shares of Axogen, Inc. - Common Stock are outstanding?
Axogen, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>